Needham Investment Management’s Agile Therapeutics AGRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-175	Closed	-$171K	–	131
2021 Q4	$171K	Sell	175 -193	-52%	-$272K	0.02%	117
2021 Q3	$706K	Hold	368	–	–	0.09%	100
2021 Q2	$978K	Hold	368	–	–	0.14%	87
2021 Q1	$1.53M	Buy	368 +68	+23%	+$368K	0.21%	78
2020 Q4	$1.72M	Buy	+300	New	+$1.77M	0.29%	74
2019 Q4	–	Sell	-28	Closed	-$65K	–	103
2019 Q3	$65K	Sell	28 -20	-42%	-$49.3K	0.02%	86
2019 Q2	$139K	Sell	48 -32	-40%	-$89.4K	0.05%	83
2019 Q1	$242K	Buy	80 +40	+100%	+$84.8K	0.08%	77
2018 Q4	$46K	Sell	40 -75	-65%	-$115K	0.02%	83
2018 Q3	$85K	Sell	115 -8	-7%	-$5.86K	0.03%	85
2018 Q2	$121K	Sell	123 -91	-43%	-$319K	0.03%	90
2018 Q1	$1.1M	Buy	214 +10	+5%	+$66.1K	0.31%	57
2017 Q4	$1.1M	Sell	204 -48	-19%	-$447K	0.29%	60
2017 Q3	$2.25M	Buy	252 +37	+17%	+$284K	0.57%	50
2017 Q2	$1.61M	Buy	215 +102	+90%	+$706K	0.43%	52
2017 Q1	$725K	Buy	113 +43	+61%	+$216K	0.19%	72
2016 Q4	$799K	Buy	70 +47	+204%	+$659K	0.2%	73
2016 Q3	$314K	Buy	+23	New	+$328K	0.08%	82

Other funds holding AGRX